-
Authors :
Collins M; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Pehrson R
Subjects: Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/metabolism ; Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/antagonists & inhibitors ; Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/Nuclear Receptor Subfamily 1, Group F, Member 3*/genetics
-
Source:
PloS one [PLoS One] 2025 Jan 16; Vol. 20 (1), pp. e0317090. Date of Electronic Publication: 2025 Jan 16 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet
تفاصيل العنوان